InvestorsHub Logo
Followers 22
Posts 7075
Boards Moderated 0
Alias Born 05/14/2011

Re: None

Tuesday, 01/04/2022 5:36:33 AM

Tuesday, January 04, 2022 5:36:33 AM

Post# of 892
Poking around about last month's 8k listing a press-release on the status of TYME's COVID-19 sidebar project

TYME-19 (COVID project) was first announced in August 2020. Under the old Board of Directors, all swept OUT of offices held when we got $100 million Institutional buy in.

New CEO, Richie Cunningham, had one mention of TYME-19 in passing. All focus moving our R&D assets to:
....(1) Jump-start our dormant Breast Cancer Therapy
Trial .
....(2) Continue our collaborative trials in pancreatic and sarcoma cancers.

Cunningham has indicated he wasn't into Press Releases once underway. 8k registrations ln project developments would be where our progress is listed.

Most missed the close timing between the 8k/PR and Army's own COVID announcement. Couple of returns on same search on web follow.

Series of preclinical studies supports the Army's pan-coronavirus vaccine Dec 16, 2021 — – A series of recently published preclinical study results show that the Spike Ferritin Nanoparticle (SpFN) COVID-19 vaccine developed by ...

TYME Technologies, Inc. Announces Additional Encouraging Preclinical Data ...
Dec 14, 2021 — The Company believes that TYME-19, a synthetic bile acid, may have differentiated mechanisms that could offer alternatives for COVID-19 ...

Just intesting fo me. Army and TYME both finding success in micro-biological processes that have similar molecular proteins and acids. Then it gets complicated.

Nuther note. The bi-weekjy sell-downs by our founder who together still hold 45 million shares around 1/3d of whole OS.

They are sideliners more than insiders. Demurjian kicked out after a n error in judgement in 2019 on a small breast cancer trial.

Hoffman pushed out in 2020 with the $100 mill buy in and arrival kf Richie Cunningham. By the registrations with SEC, each sell down is controlled as incremental. Only 4-to-8% of each foundeing-sidelinerd' holdings are registered.

First half of calendar year 2022 is supposed to hold great news on sarcoma. Maybe COVID as well.

Staying long. We have a whole new Board of Directors since the $100 mill.

Things are moving.
Good Luck to us all